Search

Your search keyword '"Malats, Núria"' showing total 933 results

Search Constraints

Start Over You searched for: Author "Malats, Núria" Remove constraint Author: "Malats, Núria"
933 results on '"Malats, Núria"'

Search Results

1. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization.

2. Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancer

3. List of contributors

7. A Pan-Cancer Analysis of Tumor-Infiltrating B Cell Repertoires

8. Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems

10. Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features

11. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights

13. Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non–muscle-invasive Bladder Cancer

14. Demographic Analysis of Cancer Research Priorities and Treatment Correlations

15. A liquid biomarker signature of inflammatory proteins accurately predicts early pancreatic cancer progression during FOLFIRINOX chemotherapy

16. Integrative eQTL analysis of tumor and host omics data in individuals with bladder cancer

17. Challenges in the integration of omics and non-omics data

18. Tumor-infiltrating b-and T-cell repertoire in pancreatic cancer associated with host and tumor features

19. A pan-cancer analysis of tumor-infiltrating B cell repertoires

20. Integration analysis of three omics data using penalized regression methods: an application to bladder cancer

21. Bratislava Statement: consensus recommendations for improving pancreatic cancer care

22. Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis

23. Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry

24. The protective effect of atopic diseases against pancreatic cancer is not driven by Th2-biomarkers

25. Integration of metabolome and microbiome omics layers toward pancreatic cancer risk prediction

27. Complement system genetic variability shapes pancreatic cancer risk

30. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

31. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer

32. Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment Interactions

33. Enhanced antitumour immunity following neoadjuvant chemoradiotherapy mediates a favourable prognosis in women with resected pancreatic cancer.

34. Mobilising Collaboration among Stakeholders to Optimise the Growing Potential of Data for Tackling Cancer

36. Supplementary Figure S2 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization

37. Supplementary Table S6 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization

38. Data from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization

40. Gallbladder disease, cholecystectomy, and pancreatic cancer risk in the International Pancreatic Cancer Case-Control Consortium (PanC4)

42. 7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium

43. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the Breast Cancer Association Consortium: a combined case-control study

47. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization

48. Abstract 6075: Comprehensive genomic characterization of early-stage bladder cancer from 438 patients by whole genome- and exome sequencing

50. Supplementary Table 2 from Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study

Catalog

Books, media, physical & digital resources